Deregulation of CREB signalling is associated with several neurodegenerative diseases, for instance, Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and ALS.22, 24, 25, 26. This evidence concerns the gene CREB1 and amyotrophic lateral sclerosis.